Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMPACT: ACE/ARB Management Before Cardiac Surgery
NCT02096406Phase 2Completed
- Sponsor
- University of Alberta
- Start
- Apr 2014
- Primary completion
- Mar 2018
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in coronary artery disease (CAD) and valvular heart disease (VHD), sponsored by University of Alberta. Primary endpoint: Adherence to the study protocol. Started Apr 2014; status: completed.
02
Conditions
coronary artery disease (CAD)valvular heart disease (VHD)
Beyond the preview
Go deeper on NCT02096406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02096406.